Cardiotoxicity Associated With Chimeric Antigen Receptor (CAR)-T Cell Therapy for Hematologic Malignancies: a prospective cohort study.
Read more about the study here.
Each month, our team of global experts identifies and summarizes the key findings of the latest cardio-oncology studies during a half-hour virtual presentation and panel discussion. As cancer and cardiovascular care are constantly evolving, our insights and analysis empower viewers to integrate the latest information into their clinical practice seamlessly.
Panelists
Presenter
